Notify me when ROBERT DISBROW files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EPRX | Eupraxia Pharmaceuticals Inc. | Common Shares, with no par value | 7% | $21,052,085 | 3,568,150 | Robert Disbrow | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|